Products
-
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensAnmial BBB ModelsCell Lines for BBB Modeling
- Immortalized CellsPrimary CellsStem Cells
Human Homer1 ELISA Kit (AC3619)
Cat.#: ASET-2208
Specifications
Description Human Homer1 ELISA Kit allows for the in vitro quantitative determination of human Homer1 concentrations in serum, plasma, tissue homogenates, and other biological fluids. The kit employs the sandwich enzyme immunoassay technique. Size 96T Sample Type Serum, plasma, tissue homogenates, and other biological fluids. Reactivity Human Unit 1 kit Packaging Kit of pre-coated 96 well microplates (12 x 8 well strips) Detection Type Colorimetric Assay Type Quantitative Sensitivity 9.375 pg/ml Precision Intra-assay CV: < 8%
Inter-assay CV: < 10%Product Range 15.625-1000 pg/mL Assay Time 4h 30m Storage Store the unopened kit at +4°C. Shipping Wet ice Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Assay Type Price ASET-1796 Human iNOS ELISA Kit (AC3207) Quantitative inquiry ASET-1176 Human CD97 ELISA Kit (AC2587) Quantitative inquiry ASET-1835 Human Hemojuvelin ELISA Kit (AC3246) Quantitative inquiry ASET-2253 Mouse Fat3 ELISA Kit (AC3664) Quantitative inquiry ASET-1870 Human Myelin Oligodendrocyte Glycoprotein ELISA Kit (AC3281) Quantitative inquiry ASET-1103 Mouse LC3B ELISA Kit (AC2514) Quantitative inquiry ASET-1471 Mouse GSK3 beta ELISA Kit (AC2882) Quantitative inquiry ASET-1777 Human Drebrin ELISA Kit (AC3188) Quantitative inquiry ASET-1014 Human iNOS ELISA Kit (AC2425) Quantitative inquiry ASET-1146 Human Urocortin ELISA Kit (AC2557) Quantitative inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
Quick Links0Inquiry Basket